Adjuvant aromatase inhibitors and emerging quality-of-life considerations
Expert Rev Anticancer Ther
.
2008 Jan;8(1):1-4.
doi: 10.1586/14737140.8.1.1.
Authors
Susanne Briest
,
Vered Stearns
PMID:
18095876
DOI:
10.1586/14737140.8.1.1
No abstract available
Publication types
Editorial
MeSH terms
Aromatase Inhibitors / therapeutic use*
Breast Neoplasms / drug therapy*
Chemotherapy, Adjuvant
Female
Humans
Quality of Life*
Substances
Aromatase Inhibitors